Proteogenix
Schiltigheim, Grand Est
- UEI
- CP2GCU4XTVM7
- CAGE
- FBFY6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- NAICS codes registered in SAM.gov
-
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) Primary
- 325412 Pharmaceutical Preparation Manufacturing
- 325413 In-Vitro Diagnostic Substance Manufacturing
- 325414 Biological Product (except Diagnostic) Manufacturing
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration date
- Physical address
- 19 Rue de la Haye, 67300 Schiltigheim, France
- Website
- proteogenix.science
- Founded
- 2003
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| [25-013787] nhlbi cellular and molecular therapeutics laboratory requires the phage library in order to perform upcoming… | National Heart Lung and Blood Institute | $15,440 | |
| [25-012037] nhlbi cellular and molecular therapeutics laboratory requires the phage library in order to perform upcoming… | National Heart Lung and Blood Institute | $22,190 | |
| [25-000153] NIH nhlbi DIR cmtb laboratory requires additional results from a previous screening service in order to… | National Heart Lung and Blood Institute | $10,620 | |
| Phage-display VHH antibody screening service to develop in vivo gene therapy | National Heart Lung and Blood Institute | $29,700 | |
| Phage-display library screening services to develop in vivo gene therapy. | National Heart Lung and Blood Institute | $46,260 |
About Proteogenix
Proteogenix is a for-profit biotechnology manufacturer based in Schiltigheim, France, with international organizational status. Registered in SAM.gov since August 2020 and valid through February 2026, the company specializes in advanced biotechnological services and products. While limited publicly available information exists about the company's comprehensive background, their federal contract awards demonstrate expertise in sophisticated laboratory screening and research support services.
Proteogenix has exclusively worked with the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health, on multiple purchase order contracts focused on gene therapy research. Their specific services have included phage-display library screening, VHH antibody screening, and laboratory screening services to support genetic analysis and gene modification experiments. These contracts, ranging from $10,620 to $46,260, have been awarded through full and open competition with no specific set-aside designations. The contracts consistently target advanced research objectives, particularly in developing hematopoietic stem cell (HSC) therapy and in vivo gene therapy methodologies. All contracts have been structured as firm fixed-price purchase orders with completion dates between April and November 2025, indicating Proteogenix's ongoing collaborative relationship with NHLBI's Cellular and Molecular Therapeutics Laboratory and Center for Molecular Therapeutics and Bioanalytics.
Quick answers
What is Proteogenix's UEI?
Proteogenix's Unique Entity ID (UEI) in SAM.gov is CP2GCU4XTVM7.
What is Proteogenix's CAGE code?
Proteogenix's CAGE code is FBFY6.
What is Proteogenix's primary NAICS code?
Proteogenix's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Proteogenix located?
Proteogenix's physical address in SAM.gov is 19 Rue de la Haye, 67300 Schiltigheim, France.
Is Proteogenix registered in SAM.gov?
Yes. Proteogenix's SAM.gov registration is active through February 16, 2027.
What is Proteogenix's most recent federal award?
Proteogenix's most recent federal contract award is [25-013787] nhlbi cellular and molecular therapeutics laboratory requires the phage library in order to perform upcoming… (75N92025P00347), from National Heart Lung and Blood Institute, on August 28, 2025.
On GovTribe
See Proteogenix's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors